← Back to Search

Lithotripsy Technology

MOSES Laser Technology for Kidney Stones

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Kidney or ureteral stone requiring laser lithotripsy fragmentation
Must not have
Atypical collecting system anatomy that prolongs the case (ureteral stricture, malrotated kidney, infundibular stenosis, ureteral duplication)
Infectious, struvite stones
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if using a laser to fragment kidney stones is more efficient and safe when a specific type of modulation is used.

Who is the study for?
This trial is for adults over 18 with kidney or ureteral stones needing laser fragmentation. It's not suitable for those under 18, patients with infectious struvite stones, or unusual urinary tract anatomy that could complicate the procedure.
What is being tested?
The study tests MOSES laser technology during ureteroscopy to see if it can make breaking up kidney stones safer and more efficient, potentially reducing the time spent using the laser and overall operating room time.
What are the potential side effects?
While specific side effects are not listed, typical risks of laser lithotripsy may include bleeding, infection, stone fragments blocking urine flow, and discomfort from the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I need a laser treatment for my kidney or ureter stone.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have unusual kidney or ureter structures that could complicate surgery.
Select...
I have struvite kidney stones.
Select...
I am younger than 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The primary endpoint of interest will be reduction in total OR time
The primary endpoint of interest will be reduction in total laser time
Secondary study objectives
Complication rates using Clavien-Dindo score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: MOSES laser lithotripsyActive Control1 Intervention
MOSES technology used for stone fragmentation in ureteroscopy
Group II: Standard laser lithotripsyActive Control1 Intervention
standard of care for stone fragmentation in ureteroscopy

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,035 Previous Clinical Trials
1,218,863 Total Patients Enrolled
4 Trials studying Kidney Stones
173 Patients Enrolled for Kidney Stones

Media Library

MOSES (Lithotripsy Technology) Clinical Trial Eligibility Overview. Trial Name: NCT03995758 — N/A
Kidney Stones Research Study Groups: MOSES laser lithotripsy, Standard laser lithotripsy
Kidney Stones Clinical Trial 2023: MOSES Highlights & Side Effects. Trial Name: NCT03995758 — N/A
MOSES (Lithotripsy Technology) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03995758 — N/A
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top